Sign In
Buy CRL
$232.51
-2.11 (-0.90%)
At Close: Jul 31, 2026
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
08:00am, Wednesday, 13'th May 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU
Charles River Laboratories International Inc (CRL) Stock Down 5.2% -- Now Undervalued? GF Score: 79/100
01:23am, Tuesday, 12'th May 2026
On May 12, 2026, Charles River Laboratories International Inc (CRL) shares fell 5.2%, bringing the current price to $168.46. The stock has experienced a 52-week
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
10:16am, Monday, 11'th May 2026
Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
08:00am, Monday, 11'th May 2026
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to
Charles River Laboratories International Q1 Earnings Call Highlights
07:05pm, Saturday, 09'th May 2026
Charles River Laboratories International NYSE: CRL reported first-quarter 2026 results that management said were in line to slightly ahead of its prior outlook, while reaffirming its full-year organic
LH vs. CRL: Which Stock Is the Better Value Option?
12:41pm, Friday, 08'th May 2026
Investors interested in stocks from the Medical Services sector have probably already heard of Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two stocks offers value in
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
11:11am, Friday, 08'th May 2026
Charles River Laboratories International, Inc. (NYSE:CRL) posted upbeat earnings for the first quarter, but lowered its FY2026 forecast on Thursday.
Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript
03:21pm, Thursday, 07'th May 2026
Charles River Laboratories International, Inc. (CRL) Q1 2026 Earnings Call Transcript
Charles River Q1 Review: Near-Term Stability But Long-Term Risks (Downgrade)
12:26pm, Thursday, 07'th May 2026
Charles River Laboratories is downgraded to 'Sell' as shares have rallied 57% in the past year, outpacing fundamentals. Despite Q1 stabilization, organic revenue declined 1.5% and margins compressed,
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down
11:20am, Thursday, 07'th May 2026
Charles River beats Q1 earnings and revenue estimates, but margin declines and weak organic growth in key segments send shares lower in pre-market.
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics
10:31am, Thursday, 07'th May 2026
The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street est
Charles River Laboratories (CRL) Surpasses Q1 Earnings and Revenue Estimates
09:56am, Thursday, 07'th May 2026
Charles River Laboratories (CRL) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $2.34 per share a year ago.
Charles River Associates (CRA) Reports Financial Results for the First Quarter of 2026
08:05am, Thursday, 07'th May 2026
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fisc
Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.57 Per Common Share
08:00am, Thursday, 07'th May 2026
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that its Board of Directors ha
Charles River beats quarterly estimates on steady demand for drug development services
07:54am, Thursday, 07'th May 2026
Contract drug developer Charles River Laboratories on Thursday beat Wall Street expectations for first-quarter results, helped by improved demand for its drug discovery and development services.
